Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
March 3, 2026
Umbilical Cord Blood Transplant (UCBT) Is an Attractive Option for Patients with Non-Malignant Diseases; A CIBMTR Report.
CM
Caridad A Martinez
DN
D. NGUYEN
Baylor College of Medicine
KN
Ken Nobleza
Ver todo
Puntos clave
Umbilical cord blood transplant demonstrates potential benefits for patients with non-malignant diseases, enhancing treatment prospects.
Over 1000 patients received umbilical cord blood transplant, showing positive outcomes across various conditions.
CIBMTR analysis of transplant records provides insights into treatment efficacy and patient survival rates.
These findings suggest umbilical cord blood transplant may be a significant option for alternative therapies in diverse patient populations.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Martinez et al. (Sun,) studied this question.
synapsesocial.com/papers/69a7603fc6e9836116a2ccbc
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.149
Umbilical Cord Blood Transplant (UCBT) Is an Attractive Option for Patients with Non-Malignant Diseases; A CIBMTR Report. | Synapse